Insider · CIK 0001248398
Joan E Herman
director
Files at EHC (Encompass Health Corp), IONS (IONIS PHARMACEUTICALS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +73 | $0.00 | $0 | 47,752 | Oct 16, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +4,079 | $0.00 | $0 | 46,086 | Jul 17, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -4,079 | $0.00 | $0 | 5,220 | Jul 17, 2025 |
| Jul 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +74 | $0.00 | $0 | 47,679 | Jul 16, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +11,518 | $0.00 | $0 | 11,518 | Jul 2, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +5,220 | $0.00 | $0 | 9,299 | Jul 2, 2025 |
| May 1, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 47,605 | May 2, 2025 |
| Apr 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +76 | $0.00 | $0 | 46,181 | Apr 16, 2025 |
| Jan 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +83 | $0.00 | $0 | 46,105 | Jan 17, 2025 |
| Oct 15, 2024 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +81 | $0.00 | $0 | 46,022 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.